Cargando…
Albumin Infusion in Critically Ill COVID-19 Patients: Hemodilution and Anticoagulation
Hypercoagulation is one of the major risk factors for ICU treatment, mechanical ventilation, and death in critically ill patients infected with SARS-CoV-2. At the same time, hypoalbuminemia is one risk factor in such patients, independent of age and comorbidities. Especially in patients with severe...
Autor principal: | Ramadori, Giuliano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268290/ https://www.ncbi.nlm.nih.gov/pubmed/34281177 http://dx.doi.org/10.3390/ijms22137126 |
Ejemplares similares
-
Albumin infusion for the critically ill – is it beneficial and, if so, why and how?
por: Das, Undurti N
Publicado: (2015) -
Use or Misuse of Albumin in Critical Ill Patients
por: Saner, Fuat Hakan, et al.
Publicado: (2023) -
ANTICOAGULATION, BLEEDING, AND IMMUNOTHROMBOSIS IN CRITICALLY ILL PATIENTS WITH COVID-19
por: PAEZ VARGAS, JUAN, et al.
Publicado: (2021) -
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
Publicado: (2021) -
CRITICALLY ILL COVID-19 PATIENTS AND THERAPEUTIC ANTICOAGULATION WITH HEPARIN
por: Vu, Michael, et al.
Publicado: (2022)